CCT2: Chaperonin Containing TCP1 Subunit 2

A key molecular chaperone in protein folding and cellular homeostasis

Gene Information Card

Symbol CCT2
Full Name Chaperonin Containing TCP1 Subunit 2
Gene Type Protein coding
Chromosomal Location 12q15
NCBI Gene ID 10576 ncbi.nlm.nih.gov/gene/10576
Ensembl ID ENSG00000166226
UniProt ID P78371
OMIM ID 605139
HGNC ID 1615
Aliases CCTB, TCP-1-beta, CCT-beta, 99D8.1

Description

CCT2 encodes the beta subunit of the eukaryotic chaperonin containing TCP1 (CCT) complex, a group II chaperonin essential for the ATP-dependent folding of cytosolic proteins, including actin and tubulin. The CCT complex is composed of eight distinct subunits (CCT1-8) that form a double-ring structure. CCT2 is involved in cellular processes such as cell cycle progression, cytoskeletal organization, and response to stress. Mutations and altered expression of CCT2 have been implicated in various cancers and neurodegenerative disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary spastic paraplegia (HSP) CCT2 mutations impair protein folding capacity, leading to axonal degeneration ClinVar: pathogenic variants reported
Colorectal cancer CCT2 overexpression promotes cell proliferation and metastasis via enhanced folding of oncoproteins COSMIC: somatic mutations and copy number gains
Breast cancer CCT2 upregulation correlates with poor prognosis and chemoresistance PubMed: expression analysis
Alzheimer's disease CCT2 dysfunction contributes to tau aggregation and proteotoxicity UniProt: interaction with tau

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 28.5 High
Testis 22.3 High
Liver 18.7 Medium
Heart 15.2 Medium
Lung 12.1 Medium
Pancreas 9.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 32.4 Cervical cancer cell line
HEK293 29.1 Embryonic kidney cells
HepG2 25.6 Hepatocellular carcinoma
MCF7 21.3 Breast cancer cell line
A549 18.9 Lung adenocarcinoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1135C>T (p.Arg379Cys) Missense <0.01% Loss of ATPase activity; associated with HSP
c.1492G>A (p.Glu498Lys) Missense <0.01% Impaired complex assembly; pathogenic in HSP
c.1246A>G (p.Thr416Ala) Missense 0.02% Reduced folding efficiency; cancer-associated
c.1789C>T (p.Arg597Trp) Missense <0.01% Dominant-negative effect; neurodegeneration
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg379Cys, p.Glu498Lys) reduce ATPase activity and chaperonin function, leading to protein misfolding and cellular stress.

Gain of Function (GOF)

Not well characterized; overexpression in cancers may confer gain-of-function by enhancing folding of oncoproteins.

Dominant Negative (DN)

p.Arg597Trp disrupts CCT complex integrity, interfering with wild-type subunits and causing dominant-negative effects.

Gene Ontology (GO)

ATP binding (GO:0005524) chaperonin-containing T-complex (GO:0005832)
protein folding (GO:0006457) • cellular protein metabolic process (GO:0044267)
tubulin complex assembly (GO:0007021) • unfolded protein binding (GO:0051082)

Pathways

Chaperonin-mediated protein folding (Reactome: R-HSA-390466)
CCT complex pathway (KEGG: hsa03050)
Proteasome degradation (interaction with misfolded proteins)

Protein Summary

CCT2 is a 535-amino-acid protein (molecular weight ~57 kDa) that forms the beta subunit of the CCT chaperonin complex. It contains an equatorial ATP-binding domain and an apical substrate-binding domain. CCT2 binds ATP and undergoes conformational changes to encapsulate and fold client proteins such as actin, tubulin, and cell cycle regulators. The protein is highly conserved across eukaryotes and is essential for cell viability.

Related Products

Product name Cat.No. Species Gene ID
Contact Us
*
*
*
*
How did you hear about us: